Stress-induced reactivation of Epstein-Barr virus in astronauts

被引:56
|
作者
Stowe, RP [1 ]
Pierson, DL
Feeback, DL
Barrett, ADT
机构
[1] Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA
[2] NASA, Lyndon B Johnson Space Ctr, Life Sci Res Labs, Houston, TX 77058 USA
关键词
herpesvirus; Epstein-Barr virus; spaceflight; microgravity; latent virus reactivation;
D O I
10.1159/000026453
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Herpesviruses are leading causes of infectious blindness and death in immunocompromised individuals. Impaired cellular immunity, which is known to result in increased frequency and severity of herpesvirus infections, has been demonstrated both during and after spaceflight. Therefore, we examined whether Epstein-Barr virus (EBV), a well-characterized latent herpesvirus, undergoes reactivation in astronauts. Sera from Shuttle astronauts, taken before and after spaceflight, were examined for evidence of EBV reactivation. The geometric mean antibody titer to EBV viral capsid antigen (VCA) was significantly increased prior to flight compared to baseline (p = 0.0001). After spaceflight, evidence of acute lytic replication was found in which 8- to 64-fold increases in EBV early antigen (EA) antibodies occurred without significant increases in antibodies to measles virus. Additionally, stress-induced shifts in circulating leukocytes and elevated levels of urinary cortisol and epinephrine were found. Overall, significant increases in EA or high VCA/EA antibody titers were found in 8 of 23 (35%) male astronauts and 3 of 5 (60%) female astronauts. These results indicate that stress reactivates EBV prior to flight and suggest that acute lytic replication of EBV occurs during spaceflight. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [21] Encephalomyeloradiculopathy associated with Epstein-Barr virus: primary infection or reactivation?
    Merelli, E
    Bedin, R
    Sola, P
    Gentilini, M
    Pietrosemoli, P
    Meacci, M
    Portolani, M
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 96 (06): : 416 - 420
  • [22] Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus
    Huggins, ML
    Todd, I
    Powell, RJ
    RHEUMATOLOGY INTERNATIONAL, 2005, 25 (03) : 183 - 187
  • [23] Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation
    Thome, Marcos P.
    Borde, Chloe
    Larsen, Annette K.
    Henriques, Joao A. P.
    Lenz, Guido
    Escargueil, Alexandre E.
    Marechal, Vincent
    ANTIVIRAL RESEARCH, 2019, 172
  • [24] Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivation
    Borde, Chloe
    Escargueil, Alexandre E.
    Marechal, Vincent
    ANTIVIRAL RESEARCH, 2023, 217
  • [25] An evaluation of a polyantigenic ELISA to detect Epstein-Barr virus reactivation
    Gutiérrez, J
    Rodríguez, M
    Soto, MJ
    Suarez, S
    Morales, P
    Piédrola, G
    Maroto, MD
    MICROBIOS, 2001, 106 (413) : 49 - 54
  • [26] The influence of psychological stress on immunoregulation of latent Epstein-Barr virus
    Benschop, RJ
    Jabaaij, L
    Oostveen, FG
    Vingerhoets, AJJM
    Ballieux, RE
    STRESS MEDICINE, 1998, 14 (01): : 21 - 29
  • [27] Epstein-Barr virus
    Nicolas, JC
    Marechal, V
    Dehee, A
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1997, 181 (06): : 981 - 997
  • [28] Epstein-Barr virus induced renal leiomyoma
    Krishnan, R
    Freeman, JA
    Creager, AJ
    JOURNAL OF UROLOGY, 1999, 161 (01) : 212 - 212
  • [29] DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma
    Choi, Su Jin
    Shin, Yu Su
    Kang, Byung Woog
    Kim, Jong Gwang
    Won, Kyoung-Jae
    Lieberman, Paul M.
    Cho, Hyosun
    Kang, Hyojeung
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (08) : 894 - 905
  • [30] DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma
    Su Jin Choi
    Yu Su Shin
    Byung Woog Kang
    Jong Gwang Kim
    Kyoung-Jae Won
    Paul M. Lieberman
    Hyosun Cho
    Hyojeung Kang
    Archives of Pharmacal Research, 2017, 40 : 894 - 905